Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for the preparation of zolmitriptan, salts and solvates thereof

A solvate and organic solvent technology, applied in the field of preparing zolmitriptan and its pharmaceutically acceptable salts and solvates, and preparing an active pharmaceutical ingredient zolmitriptan, can solve the problem of low yield and difficulty in scaling up industrial scale , low purity and other problems, to achieve the effect of high yield

Inactive Publication Date: 2010-11-10
GENERICS UK LTD
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0034] Thus, the methods disclosed in the prior art for the preparation of zolmitriptan (I) have various disadvantages such as multi-step processing, low yield, low purity, and difficulty in scaling up to industrial scale

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for the preparation of zolmitriptan, salts and solvates thereof
  • Process for the preparation of zolmitriptan, salts and solvates thereof
  • Process for the preparation of zolmitriptan, salts and solvates thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0132] Embodiment 1-preparation of zolmitriptan (I)

[0133] (S)-4-(4-Aminbenzyl)-1,3-oxazolidin-2-one (IX) (100 g) was added to water (400 ml, 4.0 volumes) and concentrated HCl was added at 25-30 °C (200ml, 2.0 volumes). The solution was cooled to 5°C to -10°C and a solution of sodium nitrite (54 g, 1.5 eq) in water (400 ml, 4.0 vol) was added maintaining the temperature below -5°C. After the addition was complete, the reaction mixture was stirred for 3 hours resulting in formation of diazonium chloride (XV) in solution.

[0134] To a pre-dissolved stannous chloride solution (234.5 g, 2.0 equiv in 200 ml, 2.0 volumes of HCl) was slowly added a solution of diazonium chloride (XV) at 5°C-10°C. The mixture was stirred at 5°C-10°C for 4 hours. After completion of hydrazine formation (measured by TLC), the pH of the reaction mixture was adjusted from about pH 2 to pH 8-9 at 25°C to 30°C by using sodium carbonate (100 g) to generate (S)-4-(4- Hydrazinebenzyl)-1,3-oxazolidin-2-o...

Embodiment 2

[0144] Example 2 - Crystallization of Zolmitriptan (I)

[0145] Pure zolmitriptan (I) obtained above was crystallized from isopropanol as follows. Pure zolmitriptan (40.0 g) was dissolved in isopropanol (200 ml) at 45-50°C to give a clear solution. To the clear solution, Norit Supra B activated carbon (4.0 g, 10% w / w) was added and the mixture was heated at 45-50°C for 1 hour. The solution is then passed through the Celite Bed filter and concentrate the filtrate to about 100ml under reduced pressure. The resulting suspension was cooled to 0-5°C and stirred for 1 hour. The crystallized zolmitriptan (I) was filtered and dried at 45-50° C. under reduced pressure until a constant weight was obtained (about 6 hours).

[0146] Yield: 87% (w / w)

[0147] HPLC purity: 99.94%

[0148] By following similar experimental conditions, by using different solvents or mixtures of solvents such as methanol, ethanol, n-propanol, tert-butanol, pentanol, acetone, methyl ethyl ketone, diethyl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to an improved process for the preparation of the activepharmaceutical ingredient zolmitriptan. In particular, it relates to an efficient process for the preparation of zolmitriptan and its pharmaceutically acceptable salts and solvates.

Description

technical field [0001] The present invention relates to an improved process for the preparation of the active pharmaceutical ingredient zolmitriptan (or zolmitriptan). In particular, it relates to an efficient process for the preparation of zolmitriptan and pharmaceutically acceptable salts and solvates thereof. Background technique [0002] Zolmitriptan (I), chemical name (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxa Oxazolidinone, a selective serotonin serotonin 1D (5-HT 1D ) receptor antagonists, currently marketed for the acute treatment of the headache phase of migraine attacks with or without aura. [0003] [0004] Zolmitriptan is structurally derived from tryptamine. Its therapeutic activity in the treatment of migraine can be attributed to its presence in 5-HT 1B and 5-HT 1D Antagonistic effects on receptors on extracerebral intracranial vessels thought to become dilated during disease onset and on the trigeminal sensory nerves innervating...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/06A61K31/4178A61P25/06
CPCC07D413/06A61P25/04A61P25/06A61P9/00
Inventor 德巴希什·达塔维纳亚克·G·戈雷马赫什库马·S·加达卡尔基兰·波克哈尔卡尔基兰·帕坦加里
Owner GENERICS UK LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com